- Home
- Imaging vs Angiography-Led PCI: An Overview for DES Implantation
Imaging vs Angiography-Led PCI: An Overview for DES Implantation
- Prevention
Available Credit:
- 1.00
Course Published On:
Course Expiry Date:
Overview
In this session, 'Imaging vs Angiography-led PCI: An Overview for DES Implantation' part of the ‘Optimising the Use of Contemporary Invasive Imaging for PCI’ series, a leading faculty consider the fundamentals of imaging and angiography and ask what the advantages are with using an imaging-led approach to PCI.
‘Optimising the Use of Contemporary Invasive Imaging for PCI aims to offer education on proper image acquisition, interpretation, and correct decision-making to optimise the use of contemporary imaging. The programme provides an overview of the current use of intravascular ultrasound (IVUS) and optical coherence tomography (OCT), the relative advantages of each technique and real-world insight from imaging experts.
Support Statement
This programme is supported by unrestricted educational grant by Abbott. The scientific programme has not been influenced in any way by the sponsors.
Disclosure
In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.
The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.
Terms & Conditions
Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
The session of ‘Imaging vs angiography-led PCI: An overview for DES implantation’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.
Instruction to Participants
There is no fee for taking part in this online learning activity.
Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
To complete the course and claim certification participants must:
- Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
- Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Target Audience
- Cardiologists
- Interventionalists
- Physicians within the peripheral intervention space
- Imaging specialists
Learning Objectives
Upon completion of this activity, participants will be able to:
- Incorporate contemporary imaging for PCI in appropriate patients
- Differentiate between modern imaging techniques based on clinical data
- Recall best practices for image acquisition, interpretation and decision-making
- Interpret image data and make clinical decisions generated from existing case study data
Module |
Title |
Duration |
Speakers |
|---|---|---|---|
| Session 1 | Plenary Presentations; The Science Behind the Pictures, How Intravascular Imaging will Change your PCI Strategy, Post PCI Optimization | 40 minutes | Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) Margaret B McEntegart (Golden Jubilee National Hospital, Scotland, UK) Paolo Canova (Hospital Papa Giovanni XXIII, Bergamo, Italy) |
Plenary Presentations; The Science Behind the Pictures, How Intravascular Imaging will Change your PCI Strategy, Post PCI Optimization
Duration: 40 minutes
Speakers: Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) Margaret B McEntegart (Golden Jubilee National Hospital, Scotland, UK) Paolo Canova (Hospital Papa Giovanni XXIII, Bergamo, Italy)
Related Courses
- 1.25
Published:
Learning objectives
- Understand HTG as a risk factor for acute and chronic illness
- Describe current guideline directed management of HTG
- Recognise the gaps and challenges present in current guideline directed management of HTG
- Recall emerging trial data for novel pharmacological targets
- Use guidelines, trial data & expert opinion to develop individualised treatment strategies for high-risk patients
- Not accredited
Published:
Learning objectives
- Explain the relationship between sub-optimal RAASi therapy and poor cardio-renal outcomes
- Identify patients who would benefit from anti-hyperkalaemia medications
- Select appropriate anti-hyperkalaemia treatments across a range of patient profiles
- Adopt anti-hyperkalaemia medications as an approach to prolong optimal RAASi therapy
- Summarise current guideline recommendations on the use of potassium binding agents
- 1.00
Published:
Learning objectives
- Identify individuals likely to have HFpEF from initial presentation
- Refer suspected individuals for specialist assessment
- Initiate GDMT for HF as soon as patients are stable
- Initiate GDMT in HF regardless of EF and phenotype
- Initiate shared decision-making on complex HF patients with other members of the multidisciplinary team including cardiologists, GPs, nephrologists and diabetologists
- 2.00
Published:
Learning objectives
- Describe the burden of ASCVD in type 2 diabetes
- Assign risk of future CV events to individuals with type 2 diabetes
- Identify appropriate patients for GLP-1 RA therapy based on clinical trial outcome data to reduce ASCVD risk
- Recall trial data of anti-diabetes medications that reduce ASCVD risk
- Recall the pleiotropic effects of GLP-1 RAs and how these may impact CV outcomes
- Describe how early adoption of anti-diabetes therapies with proven CV benefit can positively influence QOL
- Adopt anti-diabetic therapies with proven ASCVD benefit
- 1.00
Published:
Learning objectives
- Recall the general approach to diagnosis and stratification of HCM according to the latest guidelines and expert opinion
- Apply advanced echocardiographic methodologies to equivocal HCM diagnoses
- Select appropriate imaging modalities to facilitate accurate risk stratification
- Stratify patients based on specific risk features and disease severity
- Choose suitable treatment modalities for patients based on specific disease features and severity